Issue 71, 2020

Boosting the abscopal effect of radiotherapy: a smart antigen-capturing radiosensitizer to eradicate metastatic breast tumors

Abstract

A smart antigen-capturing radiosensitizer based on hollow mesoporous titanium dioxide (HTiO2) has been developed for metastatic breast tumor treatment.

Graphical abstract: Boosting the abscopal effect of radiotherapy: a smart antigen-capturing radiosensitizer to eradicate metastatic breast tumors

Supplementary files

Article information

Article type
Communication
Submitted
11 Feb 2020
Accepted
20 Jul 2020
First published
21 Jul 2020

Chem. Commun., 2020,56, 10353-10356

Boosting the abscopal effect of radiotherapy: a smart antigen-capturing radiosensitizer to eradicate metastatic breast tumors

Y. Chen, W. Pan, P. Gao, M. Shi, T. Wu, N. Li and B. Tang, Chem. Commun., 2020, 56, 10353 DOI: 10.1039/D0CC01080D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements